Royce & Associates LP lifted its holdings in Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) by 12.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,982,089 shares of the company’s stock after buying an additional 213,300 shares during the period. Royce & Associates LP owned approximately 4.60% of Quipt Home Medical worth $6,045,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of QIPT. State Street Corp lifted its stake in Quipt Home Medical by 1.0% in the third quarter. State Street Corp now owns 621,388 shares of the company’s stock valued at $1,814,000 after purchasing an additional 6,317 shares during the last quarter. Jane Street Group LLC boosted its holdings in Quipt Home Medical by 28.5% in the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock worth $122,000 after buying an additional 9,290 shares during the period. JPMorgan Chase & Co. grew its stake in Quipt Home Medical by 68.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock valued at $89,000 after buying an additional 12,383 shares in the last quarter. Atom Investors LP purchased a new stake in shares of Quipt Home Medical during the third quarter worth $51,000. Finally, XTX Topco Ltd bought a new position in shares of Quipt Home Medical in the third quarter worth $54,000. 42.85% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Quipt Home Medical news, VP Patrick Dennis Gamble purchased 17,000 shares of the stock in a transaction on Thursday, December 26th. The shares were purchased at an average price of $2.45 per share, with a total value of $41,650.00. Following the acquisition, the vice president now directly owns 40,057 shares in the company, valued at approximately $98,139.65. The trade was a 73.73 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.40% of the stock is currently owned by company insiders.
Quipt Home Medical Trading Up 1.3 %
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last posted its earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative return on equity of 6.70% and a negative net margin of 2.90%. On average, equities analysts forecast that Quipt Home Medical Corp. will post -0.05 EPS for the current fiscal year.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Further Reading
- Five stocks we like better than Quipt Home Medical
- Consumer Discretionary Stocks Explained
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 REITs to Buy and Hold for the Long Term
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Top Stocks Investing in 5G Technology
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding QIPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report).
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.